Harvard University's settlement of two Title VI lawsuits has sparked a heated debate over its impact on free speech and protections for Jewish students. The settlement, which includes the adoption ...

A British start-up developing a breakthrough in nuclear fusion is closing in on a £60m funding deal amid reports that China has taken a surprise lead in the clean power technology. Oxford-based ...

Daily Mail UN chief hails 'breakthrough' Gaza ceasefire deal in speech Posted: January 16, 2025 | Last updated: January 16, 2025 United Nations Secretary General Antonio Guterres has welcomed the ...

A breakthrough in prostate cancer treatment ... including those that had developed a resistance to the common hormone therapy enzalutamide. Dr Adam Sharp, leader of the Translational Therapeutics ...

Denali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, tividenofusp alfa (DNL310), for the treatment of individuals with ...

After midnight 'breakthrough' officials say deal closer ... terribly in this war that Hamas started," Biden said in a speech to highlight his foreign policy achievements. The official briefed ...

WASHINGTON, Jan. 8, 2025 /PRNewswire/ -- MedStar Georgetown University Hospital is the first hospital in the Washington metropolitan area to offer Tumor-Infiltrating Lymphocyte therapy ...

CLEVELAND — A game-changing new type of radiation therapy cuts time while improving ... with complex pancreatic cancer. In another breakthrough, Dr. Angela Jia recently treated a kidney cancer ...

Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital hyperinsulinism (HI) Ersodetug continues to advance ...

ERLANGEN, Germany — In 2021, researchers in Germany reported something astounding. With a novel approach, they had put a young woman’s lupus — a case so severe that her organs were failing ...

GSK plc announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate (ADC) being evaluated ...